Show simple item record

dc.contributor.authorYoulden, D
dc.contributor.authorKhosrotehrani, K
dc.contributor.authorGreen, Adèle C
dc.contributor.authorSoyer, H
dc.contributor.authorKimlin, M
dc.contributor.authorYoul, P
dc.contributor.authorAitken, J
dc.contributor.authorBaade, P
dc.date.accessioned2016-03-30T09:37:15Zen
dc.date.available2016-03-30T09:37:15Zen
dc.date.issued2016-02en
dc.identifier.citationDiagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study. 2016, 57 (1):57-60 Australas J Dermatolen
dc.identifier.issn1440-0960en
dc.identifier.pmid26776229en
dc.identifier.doi10.1111/ajd.12429en
dc.identifier.urihttp://hdl.handle.net/10541/603961en
dc.description.abstractUsing a large (N= 25 493) population-based cohort from Queensland, Australia, we compared melanoma survival among cases with a single invasive melanoma only against those who also had a diagnosis of a single in situ melanoma. After adjustment for sex, age, body site, clinicopathological subtype, thickness and ulceration, it was found that there was no difference (P = 0.99) in 10-year melanoma-specific mortality following a diagnosis of an invasive lesion, whether or not an in situ melanoma was also present. We conclude that in situ melanomas do not alter the prognosis of an invasive melanoma.
dc.language.isoenen
dc.rightsArchived with thanks to The Australasian journal of dermatologyen
dc.titleDiagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study.en
dc.typeArticleen
dc.contributor.departmentCancer Council Queensland, Brisbane, Queensland, Australiaen
dc.identifier.journalThe Australasian Journal of Dermatologyen
html.description.abstractUsing a large (N= 25 493) population-based cohort from Queensland, Australia, we compared melanoma survival among cases with a single invasive melanoma only against those who also had a diagnosis of a single in situ melanoma. After adjustment for sex, age, body site, clinicopathological subtype, thickness and ulceration, it was found that there was no difference (P = 0.99) in 10-year melanoma-specific mortality following a diagnosis of an invasive lesion, whether or not an in situ melanoma was also present. We conclude that in situ melanomas do not alter the prognosis of an invasive melanoma.


This item appears in the following Collection(s)

Show simple item record